Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   540,054    

Indirect Shares

   247,533      
Direct Value   $43,092,104    

Indirect Value

   $21,938,850      
Total Shares   787,587      
Total Value   $65,030,954      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $914,552 Immunome Inc. $149,513 Keros Therapeutics, Inc. $0 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $914,552 Immunome Inc. $149,513 Keros Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
            Keros Therapeutics, Inc. KROS 2024-06-01 200 0    Premium*  
* Premium Members only  

Records found :    853         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 33 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-14 4 AS $89.22 $1,672,851 D/D (18,750) 290,600 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-28 4 AS $83.79 $1,675,800 D/D (20,000) 334,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-10 4 AS $89.59 $1,679,794 D/D (18,750) 290,600 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2013-05-14 4 S $70.74 $1,773,551 I/I (25,000) 20,609 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-04-11 4 AS $90.99 $1,819,800 D/D (20,000) 474,994 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-04-12 4 AS $91.26 $1,825,200 D/D (20,000) 474,994 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-05-08 4 AS $91.72 $1,834,400 D/D (20,000) 298,552 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-03-15 4 D $78.39 $1,836,364 D/D (23,426) 313,576 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-22 4 OE $26.49 $1,847,492 D/D 69,743 240,425 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-21 4 OE $26.49 $1,847,519 D/D 69,744 240,426 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-04-28 4 AS $97.58 $1,951,600 D/D (20,000) 298,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-05-07 4 AS $77.60 $1,953,121 D/D (25,000) 303,839 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-04-27 4 AS $97.73 $1,954,600 D/D (20,000) 298,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2021-05-06 4 AS $78.01 $1,957,199 D/D (25,000) 303,839 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-05-09 4 OE $67.81 $2,034,300 D/D 30,000 456,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-05-10 4 OE $67.81 $2,034,300 D/D 30,000 456,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-05-11 4 OE $67.81 $2,034,300 D/D 30,000 456,213 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-29 4 OE $38.59 $2,050,094 D/D 53,125 431,709 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-09-30 4 OE $38.59 $2,050,094 D/D 53,125 431,709 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-10-13 4 OE $38.59 $2,050,094 D/D 53,125 376,493 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-03-09 4 S $112.12 $2,130,383 I/I (19,000) 38,279 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2020-03-13 4 D $84.50 $2,615,444 D/D (30,952) 265,491 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-15 4 D $94.53 $2,660,358 D/D (28,143) 300,558 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-05-01 4 AS $114.98 $2,669,517 I/I (23,218) 33,258 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2015-04-01 4 AS $120.53 $2,717,546 I/I (22,546) 33,258 0 -
  853  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33  34   35      
  Page 33 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us